Sumitomo Dainippon Pharma Co Ltd - Depreciation and Amortization Expense

Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Depreciation-and-Amortization-Expense" stands at 9.50 Billion Japanese Yens for the trailing twelve months (TTM) period ending 12/31/2024, the lowest value since 03/31/2018.'
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -74.61 percent compared to the value the year prior.
The 1 year change in percent is -74.61.
The 3 year change in percent is -73.77.
The 5 year change in percent is -42.06.

The Serie's long term average value is 23.33 Billion Japanese Yens. It's latest available value, on 12/31/2024, is 59.27 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2017, to it's latest available value, on 12/31/2024, is +208.20%.
The Serie's change in percent from it's maximum value, on 09/30/2022, to it's latest available value, on 12/31/2024, is -77.69%.